Raymond James downgraded Vertex from Outperform to Mkt Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/17/2025 | $48.00 | Overweight | Piper Sandler |
| 4/22/2025 | $54.00 | Outperform | Exane BNP Paribas |
| 2/28/2025 | $58.00 → $31.00 | Buy → Hold | Stifel |
| 1/3/2025 | Outperform → Mkt Perform | Raymond James | |
| 12/31/2024 | $62.00 | Buy | DA Davidson |
| 11/4/2024 | $35.00 → $50.00 | Hold → Buy | Jefferies |
| 7/23/2024 | $43.00 | Outperform | Robert W. Baird |
| 3/1/2024 | $40.00 | Underperform → Neutral | BofA Securities |
Piper Sandler initiated coverage of Vertex with a rating of Overweight and set a new price target of $48.00
Exane BNP Paribas initiated coverage of Vertex with a rating of Outperform and set a new price target of $54.00
Stifel downgraded Vertex from Buy to Hold and set a new price target of $31.00 from $58.00 previously
4 - Vertex, Inc. (0001806837) (Issuer)